Genetic Signatures launches new EasyScreen™ product range at ECCMID2012
Genetic Signatures has launched a new EasyScreen™ product range at the 22nd European Congress of Clinical Microbiology and Infectious Diseases in London from 31st March to 3rd April 2012. The range includes kits for diagnosing bacterial, viral and protazoan causes of gastroenteritis direct from faeces. Dr John Melki has presented a poster outlining the…
Read MoreGenetic Signatures launches EasyScreen™ kits for the detection of Enteric Pathogens
Genetic Signatures is pleased to announce the launch of EasyScreen kits for the detection of Enteric Pathogens. The range includes kits for diagnosing bacterial, viral and protazoan causes of gastroenteritis direct from faeces. A universal sample preparation method allows for rapid efficient (automatable) nucleic acid isolation. Existing nucleic acid isolation and real-time PCR platforms can be utilized,…
Read MoreGenetic Signatures receives CE mark for EasyScreen™ C. difficile Detection Assay
Genetic Signatures is pleased to announce that it has gained the European CE-IVD Mark for its EasyScreen™ C. difficile Detection Kit. The real-time multiplex PCR assay can be used directly from patient stool samples and yields a result in approximately 3 hours. The CE-IVD approval paves the way for CE-IVD marking of the EasyScreen™ C.…
Read More